platoseedplatoseed
Diagnostic platform for early detection of liver disease
Luminist developed a non-invasive diagnostic test for the early detection and staging of liver fibrosis and non-alcoholic steatohepatitis (NASH). Luminist was acquired in 2020 by DiscernDx.
Luminist Labs positions itself as a diagnostic platform focused on the early detection of liver disease. The provided text mainly shows a domain-for-sale listing with minimal information about the actual product offering.
The text does not describe any concrete product features or how the diagnostic platform works. It only indicates a domain marketplace listing for LuMiniStLabs.com with pricing and payment options, and does not provide details about the platform's functionality, data workflow, or user experience.
Who it’s for: Unknown
Co-founder and CEO of Luminist Labs (Acquired by DiscernDx) Currently CEO @ Curebase (S18)
Formerly “Luminist”
Luminai helps automate repetitive manual work away from your mission…
Next generation infectious disease test kits
